2021
DOI: 10.3390/diagnostics11030533
|View full text |Cite
|
Sign up to set email alerts
|

SAFE: A Novel Microwave Imaging System Design for Breast Cancer Screening and Early Detection—Clinical Evaluation

Abstract: SAFE (Scan and Find Early) is a novel microwave imaging device intended for breast cancer screening and early detection. SAFE is based on the use of harmless electromagnetic waves and can provide relevant initial diagnostic information without resorting to X-rays. Because of SAFE’s harmless effect on organic tissue, imaging can be performed repeatedly. In addition, the scanning process itself is not painful since breast compression is not required. Because of the absence of physical compression, SAFE can also … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

2
41
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
6
1

Relationship

1
6

Authors

Journals

citations
Cited by 38 publications
(50 citation statements)
references
References 32 publications
2
41
0
Order By: Relevance
“…When ideal skin suppression is used, as displayed in Figure 3a, no beamformer has a practical sensitivity. If adipose and fibroglandular reference subtraction is performed, the beamformers have improved performance that is within the range of reported sensitivity estimates in the literature (74-100% in [8,9,[32][33][34][35][36][37]). The specificity of the DAS and DMAS beamformers was observed to be worse than a random classifier acting on images of healthy breasts.…”
Section: Resultssupporting
confidence: 78%
See 3 more Smart Citations
“…When ideal skin suppression is used, as displayed in Figure 3a, no beamformer has a practical sensitivity. If adipose and fibroglandular reference subtraction is performed, the beamformers have improved performance that is within the range of reported sensitivity estimates in the literature (74-100% in [8,9,[32][33][34][35][36][37]). The specificity of the DAS and DMAS beamformers was observed to be worse than a random classifier acting on images of healthy breasts.…”
Section: Resultssupporting
confidence: 78%
“…The ORR beamformer outperformed the DAS and DMAS reconstruction methods in all cases. While the specificity of ORR is relatively poor compared to existing clinical modalities, it is similar to the 62% specificity reported in [37], and the relative increase in specificity compared to the literature standard DAS and DMAS beamformers is promising. No existing technique has been demonstrated to have specificity that would be clinically acceptable, but the relative improvement of 40% (compared to DMAS) demonstrates the potential of the ORR algorithm for BMS.…”
Section: The Diagnostic Performance Of Das Dmas and Orrsupporting
confidence: 51%
See 2 more Smart Citations
“…MBI has been investigated as a novel modality for the detection of breast disease, offering a non-ionizing, non-compressive approach [4][5][6] and as a potential diagnostic management strategy in the monitoring of neoadjuvant chemotherapy [7]. To date, a total of at least 10 MBI system prototypes have been employed in human subject tests, to investigate the clinical utility of MBI [8][9][10][11].…”
Section: Introductionmentioning
confidence: 99%